Palex Spain has acquired Equipsa on December 22, 2025, in a strategic transaction that expands its presence and capabilities in the fields of ophthalmology and microsurgery in Spain.

Equipsa is a company with a solid track record in the healthcare sector, recognized for its close relationship with customers, professionalism and deep knowledge of the ophthalmology and microsurgery market. This integration will allow Palex to strengthen its positioning in these key segments and to offer more comprehensive, innovative and efficient solutions.

In this transaction, Equipsa was advised by Galán Asociados, while Palex Spain was advised by Uría Menéndez, Sagardoy Abogados, Roca Junyent and Dextra Legal.

Palex is a leading healthcare company in Spain and Europe, with a broad portfolio of products and services and a strong customer-centric approach. The complementarity between both organizations will enable the expansion of the joint offering, reinforce market responsiveness and ensure the proximity and trust-based service that has always characterized Equipsa.

Following the transaction, Equipsa will continue to operate as usual, with no changes to its regular contact procedures or administrative management.

With this integration, both companies combine talent, experience and capabilities to deliver more complete, innovative and efficient solutions, reaffirming their commitment to excellence in service, innovation and the trust of their partners and customers.

Palex Spain has also welcomed the Equipsa team, which now officially becomes part of the group, marking the beginning of a new phase of joint growth in the healthcare sector

Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream